MXCT compared with BLND: revenue, margins and what each company keeps, and the suppliers and customers both name

MXCTMaxcyte, Inc.

Mkt capRevenueRevenue

BLNDBlend Labs, Inc.

Mkt capRevenueRevenue

Compare

MXCTMaxcyte, Inc.

BLNDBlend Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MXCT

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±81.8%▲+9.45%×0.11

May 13 '26±90.0%▲+24.06%×0.27

Q1 FY26—▼−6.81%—

Jan 13 '26±65.8%▼−3.68%×0.06

BLND

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−13.71%—

Q2 FY26±49.5%▼−16.41%×0.33

= impliedMXCT realized, solidBLND realized, hatchedOne scale, both sides: full bar = 90%× = |realized| ÷ impliedSource: market data

May 8 '26

±16.5%

▼−14.81%

×0.90

Q1 FY26±26.5%▲+11.66%×0.44

MXCTMaxcyte, Inc.

1.25▼−4.21%· post 1.28

Mkt cap$130.0MRevenue$7MQ2 FY26Revenue$33MFY25

BLNDBlend Labs, Inc.

0.97▼−15.11%· post 0.97

ClosedNov 6 '26

Mkt cap$234.4MRevenue$33MQ3 FY26Revenue$124MFY25

Compare

ClosedNov 6 '26

MXCTMaxcyte, Inc.

BLNDBlend Labs, Inc.

1.25▼−4.21%post 1.28

Price

0.97▼−15.11%post 0.97

$130.0M

Mkt cap

$234.4M

Q2 FY26$7M

Revenue

$33MQ3 FY26

FY25$33M

Revenue

$124MFY25

MXCT1.25▼−4.21%vsBLND0.97▼−15.11%ClosedNov 6 '26